On April 27th, the “Conference on Anti-Aging and Regenerative Medicine Outlook and Networking for the Establishment of the Organization,” hosted by the Preparatory Office of the International Anti-Aging Regenerative Medicine Promotion Organization, was held at the Ito International Academic Research Center, University of Tokyo, in Bunkyo, Tokyo.
The event served as both a rally for the organization’s establishment and a networking session with leading academic researchers from various countries. Experts from Japan, China, Thailand, Singapore, and other countries gathered to present their research on regenerative medicine and anti-aging, engaging in meaningful discussions.
Additionally, a signing ceremony for the Basic Agreement on the establishment of the International Anti-Aging Regenerative Medicine Promotion Organization (IARO) took place, reaffirming the commitment to advancing safe and accurate regenerative medicine through shared knowledge and collaboration.
Below are the presentations from the event:
1) Professor Masahiko Kuroda (Tokyo Medical University)
“Development of a Novel Liquid Biopsy Using Genome Signatures”
2) Chairman Zhang Bin (President, China Association of Plastic Surgery)
“Current Status and Future Prospects of Regenerative Medicine in China”
3) Mr. Koichi Yamada (Executive Officer, Head of Infectious Disease Strategy, Fujifilm Toyama Chemical Co., Ltd.)
“Role of Avigan as a Broad-Spectrum Antiviral Drug in the Post-COVID Era”
4) Professor Kampon Sriwatanakul (Chairman, Thailand Health Charter)
“Scientific Quest for Longevity and to Cure Aging”
5) Professor Chee Wee Lee (Head, Aquaculture Innovation Centre, Temasek Polytechnic)
“Unlocking the Therapeutic Potential of Aquatic Animal Cells in Regenerative Medicine”
6) Professor Pongrama Ramasoota (Head of Social Environmental Medicine, Faculty of Tropical Medicine, Mahidol University, Thailand)
“Targeted Clearance of Senescent Cells using Antibody-Trim Away Technology”
7) Dr. Ruriko Tsushima (Chair, Women’s Healthcare Network, NPO)
“Femtech in Japan: Efforts from Medical and Corporate Sectors”
8) Professor Shinichiro Motohashi (Chiba University, Graduate School of Medicine, Immuno-Cell Medicine)
“Cancer Immunotherapy Using NKT Cells”
9) Dr. Chang Chang (Department of Orthopedics, University of Tokyo)
“Stem Cell Therapy Update for Osteoarthritis”
10) Dr. Richard H. Kaszynski (Co-Founder & Director, Stanford Solutions, Stanford University School of Medicine)
“Healthspan and Homeostasis: Basic Study on the Clinical Application of Nicotinamide Mononucleotide (NMN)”